Skip to main content
. 2020 May 20;34(8):1984–1999. doi: 10.1038/s41375-020-0854-5

Table 3.

Incidence of gain of chromosome 21 in hematological cancer.

Subtype Pediatric/Adult Total cases (n) Total +21 (n) % of +21 Reference
Myeloid disorders
MPN Adult 938 36 3.8 [144] and MDB
MDS Adult 3577 151 4.2 [145] and MDB
AML Pediatric 3758 319 8.5 [133] and MDB
Adult 17769 695 3.9 [134] and MDB
AMKL Pediatric 372 126 33.9 [121] and MDB
Adult 203 15 7.4 [121] and MDB
Lymphoid disorders
T-ALL Pediatric 1431 43 3.0 [146] and MDB
Adult 495 30 6.1 MDB
B-ALL Pediatric 3973 1086 27.3 MDB
Adult 1290 141 10.9 MDB
CLL Adult 1432 32 2.2 MDB
FL Adult 906 87 9.6 [140] and MDB
CTCL Adult 246 21 8.5 [139, 140] and MDB

MDB Mitelman database (updated on 15/10/2019, available at https://mitelmandatabase.isb-cgc.org), MPN myeloproliferative neoplasms, MDS myelodysplastic syndrome, AML acute myeloid leukemia, AMKL acute megakaryoblastic leukemia, T-ALL T-cell acute lymphoblastic leukemia, B-ALL B-cell acute lymphoblastic leukemia, CLL chronic lymphocytic leukemia, FL follicular lymphoma, CTCL cutaneous T-cell lymphoma.